IRWD FY 2009 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$591M

FY 2009 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$36M+62.5% YoY

Gross Profit

$36M100.0% margin

Operating Income

-$73M-201.6% margin

Net Income

-$71M-197.2% margin

EPS (Diluted)

$-1.02

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$8M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$162M

Total Liabilities

$461M

Stockholders' Equity

-$302M

Cash & Equivalents

$123M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$36M	$22M	+62.5%
Gross Profit	$36M	$22M	+62.5%
Operating Income	-$73M	-$56M	-30.1%
Net Income	-$71M	-$54M	-32.1%